Study Details

Back
Study ID 3606-CL-2001
Study Title A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Clinicaltrials.gov Identifier NCT01334918
Compound Name CVT3146 / regadenoson
Medical Indication or Disease Myocardial perfusion imaging
Study Sponsor Astellas Pharma Global Development, Inc.
Collaborator Not Applicable
Study Start Date 26-Apr-2011
Study Completion Date 02-Jul-2012
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS